We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$30M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.2M
3
IWN icon
iShares Russell 2000 Value ETF
IWN
+$10.6M
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$7.95M
5
IBM icon
IBM
IBM
+$5.84M

Top Sells

Rank Stock Value
1
TLOG
TetraLogic Pharmaceuticals Corporation
TLOG
+$10.2M
2
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$8.32M
3
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$7.79M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$5.38M
5
KMB icon
Kimberly-Clark
KMB
+$5.23M

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSDM
1376
DELISTED
BSD MEDICAL CORP (DEL)
BSDM
$52K ﹤0.01%
39,984
– –
MJES
1377
DELISTED
MAJESCO HOLDINGS INC. NEW
MJES
$48K ﹤0.01%
118,045
– –
NG icon
1378
NovaGold Resources
NG
$2.66B
$43K ﹤0.01%
+12,000
New +$40.9K
AVNR
1379
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$37K ﹤0.01%
+10,000
New +$38.1K
ALSK
1380
DELISTED
Alaska Communications Systems
ALSK
$36K ﹤0.01%
+18,500
New +$39.8K
ERN
1381
DELISTED
Erin Energy Corp
ERN
$31K ﹤0.01%
6,623
-71
-1% -$288
ESNC
1382
DELISTED
EnSync Inc
ESNC
$31K ﹤0.01%
17,968
-43,804
-71% -$59K
DVAX
1383
DELISTED
Dynavax Technologies
DVAX
$30K ﹤0.01%
1,690
– –
BODY
1384
DELISTED
BODY CENTRAL CORP COM STK
BODY
$25K ﹤0.01%
23,791
– –
PAL
1385
DELISTED
NORTH AMERICAN PALLADIUM LTD
PAL
$24K ﹤0.01%
50,000
+12,000
+32% +$6.01K
NTS
1386
DELISTED
NTS INC COM STK (NV)
NTS
$24K ﹤0.01%
12,488
-50,790
-80% -$100K
STSI
1387
DELISTED
STAR SCIENTIFIC INC
STSI
$24K ﹤0.01%
31,000
+20,000
+182% +$17.4K
GERN icon
1388
Geron
GERN
$860M
$21K ﹤0.01%
+10,580
New +$42.2K
VGZ icon
1389
Vista Gold
VGZ
$260M
$18K ﹤0.01%
34,000
+4,000
+13% +$2.4K
STAB
1390
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$17K ﹤0.01%
1,275
-700
-35% -$11.4K
ONCT
1391
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$16K ﹤0.01%
8
+1
+14% +$2.49K
PLM
1392
DELISTED
PolyMet Mining Corp.
PLM
$14K ﹤0.01%
1,000
-500
-33% -$5.75K
IMUC
1393
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$12K ﹤0.01%
250
-2,425
-91% -$119K
GMO
1394
DELISTED
General Moly, Inc.
GMO
$10K ﹤0.01%
10,000
– –
GCVRZ
1395
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$9K ﹤0.01%
29,569
-250
-0.8% -$93
EGI
1396
DELISTED
Entre Resources Ltd. Common Shares
EGI
$8K ﹤0.01%
22,000
+12,000
+120% +$4.42K
DCTH
1397
DELISTED
Delcath Systems Inc
DCTH
$3K ﹤0.01%
41
– –
CYHHZ
1398
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
+31,146
New +$1.73K
AEE icon
1399
Ameren
AEE
$30.1B
– –
-22,861
Closed -$827K
AGCO icon
1400
AGCO
AGCO
$7.76B
– –
-5,131
Closed -$304K
54 55
56
57 58

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.